Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Link opens in a new tab
Search content at Hong Kong Baptist University
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
View Scopus Profile
Ge ZHANG, Prof
Chair Professor in Chinese Medicine
,
Chinese Medicine - Teaching and Research Division
Associate Dean (Research)
,
Office of the Dean of Chinese Medicine
Director
,
Chinese Medicine - Technology Development Division
Associate Director
,
Hong Kong Traditional Chinese Medicine Phenome Research Centre
Director
,
Institute of Precision Medicine and Innovative Drug Discovery
https://orcid.org/0000-0002-7807-7695
Email
zhangge
hkbu.edu
hk
2006
2026
Research activity per year
Overview
Fingerprint
Network
Projects / Grants
(31)
Research Output
(328)
Prizes / Awards
(2)
Activities
(5)
Press/Media
(1)
Similar Scholars
(6)
Supervised Work
(16)
Fingerprint
Dive into the research topics where Ge ZHANG is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Aptamer
100%
Bone Formation
80%
Sclerostin
54%
Osteoclast
47%
Osteoblast
44%
MicroRNA
44%
Osteoporosis
42%
Rheumatoid Arthritis
39%
Long Non-coding RNA (LncRNA)
37%
Bone Loss
31%
Catenin
30%
Drug Discovery
29%
Triple-negative Breast Cancer
26%
Bone Resorption
25%
Aging
24%
Mechanical Unloading
24%
Paclitaxel
21%
Signaling Pathway
21%
Icaritin
20%
RNA Interference
20%
Bone Mineral Density
19%
Bone Anabolic Effects
19%
Triptolide
19%
In Cancer
19%
SELEX
18%
Small Interfering RNA (siRNA)
18%
Osteoblast Differentiation
18%
Actin
18%
Osteoblastic
18%
Bone Remodeling
17%
Molecular Mechanism
17%
Microtubules
17%
Delivery System
17%
Osteogenic Differentiation
16%
Nucleic Acid Aptamer
16%
Liposomes
16%
High Affinity
15%
Glucocorticoid-induced Osteoporosis
15%
Binding Affinity
14%
Overexpression
14%
Flavonoids
14%
Osteosarcoma
14%
Exosomal
14%
Cancer Therapy
13%
Traditional Chinese Medicine
13%
Colorectal Cancer
13%
Chinese Medicine
13%
Tumor
13%
Breast Cancer
13%
Modification Strategies
12%
Biochemistry, Genetics and Molecular Biology
Ossification
76%
Osteoblast
67%
Aptamer
57%
Sclerostin
37%
Osteolysis
37%
MicroRNA
34%
Osteoclast
31%
Long Non-Coding RNA
30%
Catenin
28%
Bone Remodeling
23%
Long Noncoding RNA
22%
Actin
22%
Cross-Link
22%
Epimedium
22%
Fibrinogen
22%
Stem Cell
21%
Bone Development
20%
Messenger RNA
20%
Skeletal Muscle
20%
Small Molecule
19%
Bone Density
18%
Flavonoid
18%
Drug Development
17%
Cancer Cell
16%
Adipogenesis
15%
Osteoclastogenesis
15%
Homeostasis
14%
Programmed Cell Death
13%
Nucleic Acid
13%
Synapsin I
13%
RNAI
13%
Gene Expression
12%
Bone Turnover
12%
Bone Mass
12%
Binding Affinity
12%
Casein Kinase
12%
Casein Kinase 2
12%
Vascular Endothelial Growth Factor
12%
RANKL
12%
Leporidae
11%
Cell Migration
11%
Macrophage
11%
Small Interfering RNA
11%
Wnt Signaling Pathway
11%
Oligonucleotide
11%
Tumor Progression
10%
Systematic Evolution of Ligands by Exponential Enrichment
10%
Lipid Storage
10%
Cell Proliferation
10%
Oryzias latipes
10%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
74%
Sclerostin
48%
Diseases
39%
Neoplasm
36%
Epimedium
30%
Drug Discovery
29%
Messenger RNA
29%
Malignant Neoplasm
28%
Rheumatoid Arthritis
28%
Inflammatory Arthritis
28%
Traditional Chinese Medicine
26%
Flavonoid
26%
Bone Disease
25%
Bone Necrosis
24%
microRNA
24%
Liposome
23%
Catenin
23%
Osteosarcoma
19%
Triptolide
19%
Breast Cancer
18%
Lung Cancer
18%
Biological Marker
18%
Osteoclast Differentiation Factor
18%
Paclitaxel
17%
Inflammation
16%
Triple Negative Breast Cancer
15%
Nucleic Acid
15%
Clinical Trial
15%
Deterioration
14%
Oryzias latipes
13%
Tumor Growth
13%
Chemotherapy
13%
Oral Administration
13%
Leporidae
12%
Postmenopause Osteoporosis
12%
Osteoarthritis
12%
Phytoestrogen
12%
Vasculotropin
11%
Non Small Cell Lung Cancer
11%
Long Untranslated RNA
11%
Network Pharmacology
11%
Maturity Onset Diabetes of the Young
11%
Small Interfering RNA
10%
Virtual Screening
10%
Reactive Oxygen Metabolite
10%
Natural Product
10%
Drug Delivery System
10%
Cytotoxicity
10%
Methylglyoxal
10%
Colorectal Carcinoma
10%
